Medicare Enrolled
Dr. Esam Obed, MD
Interventional Cardiology · Oxnard, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Obed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Obed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Obed
Dr. Esam Obed is an interventional cardiology specialist in Oxnard, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Obed performed 8,463 Medicare services across 3,216 unique beneficiaries.
Between the years covered by Open Payments, Dr. Obed received a total of $8,957 from 43 pharmaceutical and/or device companies across 509 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Obed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in CA
$8,957 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,463
Medicare services
Top 12% in CA for interventional cardiology
3,216
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~423 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,534 | $100 | $388 |
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
1,031 | $0 | $6 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
866 | $40 | $110 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
759 | $34 | $94 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
679 | $12 | $66 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
621 | $99 | $175 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
592 | $43 | $124 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
490 | $54 | $143 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
337 | $47 | $119 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
294 | $146 | $388 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
211 | $178 | $660 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
197 | $18 | $65 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
132 | $177 | $926 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
101 | $40 | $90 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
88 | $153 | $300 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
82 | $76 | $370 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
59 | $17 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $133 | $280 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
45 | $53 | $397 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
41 | $406 | $2,560 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
39 | $18 | $120 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
39 | $12 | $165 |
| Cardiac catheterization | 27 | $198 | $1,000 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
21 | $73 | $140 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
19 | $179 | $570 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
14 | $37 | $220 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
14 | $17 | $230 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
14 | $198 | $998 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
13 | $65 | $400 |
| Wearable defibrillator system evaluation Assessment of a wearable cardioverter defibrillator to ensure proper function and fit. |
13 | $47 | $200 |
| Stent placement and plaque removal in one vessel A procedure to clear plaque and blood clots from a single blood vessel, followed by the insertion of a stent and/or balloon dilation to keep the vessel open. |
12 | $530 | $1,800 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
11 | $11 | $35 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
11 | $20 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
16.8% medium
80.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,957
Total received (2018-2024)
Avg $1,280/year across 7 years
Top 43% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
509
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,867 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,047
2023
$1,065
2022
$1,182
2021
$1,319
2020
$1,082
2019
$1,493
2018
$1,768
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$180
Novartis Pharmaceuticals Corporation
$142
AstraZeneca Pharmaceuticals LP
$114
Kiniksa Pharmaceuticals International, plc
$108
Amgen Inc.
$88
PFIZER INC.
$78
Novo Nordisk Inc
$71
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$52
SCPHARMACEUTICALS INC.
$44
Janssen Pharmaceuticals, Inc
$42
Edwards Lifesciences Corporation
$40
Medtronic, Inc.
$28
Alnylam Pharmaceuticals Inc.
$23
AltaThera Pharmaceuticals LLC
$21
Lexicon Pharmaceuticals, Inc.
$16
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,483
Novartis Pharmaceuticals Corporation
$1,265
AstraZeneca Pharmaceuticals LP
$929
Actelion Pharmaceuticals US, Inc.
$702
Janssen Pharmaceuticals, Inc
$492
Merck Sharp & Dohme LLC
$393
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$377
E.R. Squibb & Sons, L.L.C.
$345
Amarin Pharma Inc.
$295
PFIZER INC.
$267
Abbott Laboratories
$252
SANOFI-AVENTIS U.S. LLC
$238
Boston Scientific Corporation
$221
ABIOMED
$197
Boehringer Ingelheim Pharmaceuticals, Inc.
$181
Allergan Inc.
$149
Esperion Therapeutics, Inc.
$110
Kiniksa Pharmaceuticals International, plc
$108
Novo Nordisk Inc
$102
Merck Sharp & Dohme Corporation
$93
Medtronic, Inc.
$84
Baxter Healthcare
$77
Kowa Pharmaceuticals America, Inc.
$51
Kiniksa Pharmaceuticals, Ltd.
$51
Alnylam Pharmaceuticals Inc.
$46
Lundbeck LLC
$44
SCPHARMACEUTICALS INC.
$44
Regeneron Healthcare Solutions, Inc.
$42
Edwards Lifesciences Corporation
$40
ARBOR PHARMACEUTICALS, INC.
$32
Janssen Scientific Affairs, LLC
$25
BIOTRONIK INC.
$23
Otsuka America Pharmaceutical, Inc.
$22
Kestra Medical Technology Services, Inc.
$22
AltaThera Pharmaceuticals LLC
$21
AngioDynamics, Inc.
$20
Relypsa, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Daiichi Sankyo Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
HeartFlow, Inc.
$16
Philips Electronics North America Corporation
$14
G Medical Diagnostic Services, Inc.
$14
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ANDEXXA · AVEIR · Adempas · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · CAMZYOS · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Confirm Rx · CoreValve Evolut · Corlanor · ELIQUIS · ENSITE · ENTRESTO · Edarbi · FARXIGA · FFRct · FUROSCIX · HI-TORQUE VERSACORE · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Impella · Inpefa · JARDIANCE · LEQVIO · LifeVest · Livalo · MICRA · MULTAQ · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Repatha · Reveal LINQ · Rhythmia Mapping System · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · Sotalol Hydrochloride · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
9
Per 100K population
1.1
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Obed is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Obed experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Obed performed 1,534 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Obed receive payments from pharmaceutical companies?
Yes. Dr. Obed received a total of $8,957 from 43 companies across 509 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Obed's costs compare to other interventional cardiologists in Oxnard?
Dr. Obed's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Obed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Oxnard
Browse interventional cardiologists in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology